• To document some of the deficits in our knowledge andto suggest areas for future research. • To be a resource for a future Canadian Psychiatric Association (CPA) position paper on current psychotherapies. • To state the limitations of psychotherapy in a responsible manner. Skills in the psychotherapies are considered essential in the repertoire of a competent psychiatrist. This position has been articulated by many of the world's leading psychiatric associations, including in the United States (US) (1), Britain (2), Germany (3) , and Canada (4, 5) .
The CPA (6) approved a position paper in 1986 that stated: "A psychiatrist must be competent in both psychotherapy and pharmacotherapy." The paper argued for a new researchparadigm that would put aside some of the unanswered questions about effectiveness but which would lead to useful hypotheses about what is widely known-mainly, that the psychotherapies are helpful with certain patients and that certain psychotherapies are helpful in specific populations of patients.
During the past decade, the documentation for the efficacy of the psychotherapies has accumulated. Also, the official educational bodies in psychiatry are arguing for the need to strengthen the role of the psychotherapies. This paper summarizes the evidence-based literature and recommends how best practices should derive from the new knowledge.
The Role of Psychiatry
How do the psychotherapies fit into the role of psychiatry in medicine? The Ontario Medical Association-Ontario Psychiatric Association Task Force on Psychotherapy Standards (4) suggested the following role for psychotherapy within psychiatry. "Psychiatry is a medical specialty that is grounded in biological knowledge about human nature. North American psychiatrists generally endorse a 'biopsychosocial model' that recognizes the interplay of biological, psychological and social factors in the development of psychiatric disorders and in their treatment."
The Task Force strongly endorsed the need "to continue to support medical (psychiatric) psychotherapy within the health care system. Psychiatrists have a broad knowledge base and a systematic approach to diagnosis, prognosis and treatment planning. Psychiatrists receive a detailed education in the complex interaction between mind, brain and body so they are aware of the way that medical disorders, developmental and physical changes and bodily states influence the mind, and how the mind influences the body. Throughout their training, psychiatrists learn to carry the ultimate clinical responsibility for the management of very ill patients. Psychiatrists have experience with a wide range of mental illnesses, from the minor to the most severe. Psychiatrists can use biological treatments, such as electroconvulsive therapy and pharmacological agents. The literature demonstrates that combined use of medications and psychotherapy is frequently the most appropriate and effective treatment for a significant number of psychiatric disorders."
Psychiatrists have a special role within the field of medicine as the interpreters ofsocial and psychological phenomena for their colleagues and their patients. Psychiatry is the only specialty that can act as a specific reference point for the practice of medical psychotherapy.
The Ontario Task Force (4) proposed the following definition:
Psychotherapy is any form of psychological treatment for psychiatric disorders, behavioural maladaptions, and/or other problems [This would include problems associated with medical, surgical and obstetric disorders; reactions to the illness; and psychological contributions to the pathogenesis or perpetuation of the illness.] in which a physician deliberately establishes a professional relationship with a patient for the purpose of removing, modifying or retarding existing symptoms, or attenuating or reversing disturbed patterns ofbehaviour, and of promoting positive personality growth and development.
Treatment should be based on general standards of practice developed from 1) professional standards and practice guidelines generally endorsed by peer-reviewed professional literature and/or taught in university departments ofpsychiatry and 2) ethical standards of practice maintained by professionallicensing bodies.
Psychotherapy Skills for a General Psychiatrist
Should all psychiatrists require basic psychotherapeutic skills? Copus has suggested that basic skills include being able to form a therapeutic alliance, being competent to assess psychological issues, monitoring the therapist's own feelings, creating a safe milieu, and having specific intervention skills (7) .
Cameron describes therapeutic alliance, comprehensive assessment, the ability to construct formulations leading to tailored treatment, the ability to understand quality of attachments, the need to terminate treatment effectively, an understanding of countertransference, the importance of avoiding boundary violations, and the importance of supervision and consultation skills (8) . All ofthese functions require psychotherapeutic sophistication. It is likely true that forming a good therapeutic alliance will improve compliance with other aspects of psychiatric treatment.
Summary of Evidence-Based Psychotherapies Literature 1. Cognitive-Behavioural Therapies
Hundreds of studies have examined the efficacy of cognitive and behavioural interventions for a broad range of disorders including anxiety disorders, mood disorders, schizophrenia, eating disorders, substance abuse, sexual disorders, and stress-related medical conditions. For most of these disorders, cognitive-behavioural therapy (CBT) has been shown to be of some benefit and, for many disorders, may be the treatment of choice. In addition to the huge number of published outcome studies, there are now numerous metaanalytic studies (9,10) demonstrating the efficacy of CBT for various disorders relative to other treatment modalities (for example, pharmacological treatments).
Depression
Several literature reviews (11,12) have found that CBT is an effective treatment for depression. However, there is little evidence that CBT is more effective than certain alternative treatments such as pharmacotherapy and interpersonal psychotherapy (IPT).
Panic Disorder and Agoraphobia
Panic disorder has been successfully treated with various cognitive and behavioural interventions including cognitive restructuring, interoceptive and in vivo exposure, and applied relaxation. Across a wide range of studies, an average of85% of patients treated with CBT are panic-free at posttreatment, and 88% are panic-free at follow-up (13) .
Social and Specific Phobias
There now exist over 25 studies examining the efficacy of CBT for social phobia and dozens more examining the use of CBT for specific fears and phobias. Heimberg and Juster reviewed the literature on CBT for social phobia and concluded that various treatment strategies appear to be effective for social phobia, including social-skills training, exposure, applied relaxation, and cognitive therapy (14) . CBT for social phobia appears to be equally as effective as phenelzine, and its effects last longer.
Obsessive-Compulsive Disorder
Three recent literature reviews (10, 15, 16) concluded that CBT (usually in the form of "exposure and response 205 The Canadian Journal of Psychiatry Vol 44, Suppll prevention") is an effective treatment for obsessive-eompulsive disorder (OCD). Although there was no consistent difference in efficacy between CBT and various pharmacological interventions (such as clomipramine and fluoxetine) on most measures, Abel concluded that CBT may be most beneficial for compulsive rituals, whereas pharmacotherapy may be especially helpful for patients with prominent obsessions, overvalued ideation, and depression (15) .
Generalized Anxiety Disorder
Cognitive-behavioural treatment of generalized anxiety disorder (GAD) primarily comprises cognitive therapy and various relaxation-based interventions. Recent reviews (for example, 13,17) of more than 10 studies examining the efficacy of CBT for GAD suggest that CBT is effective.
Posttraumatic Stress Disorder
Few controlled studies exist of CBT for treating posttraumatic stress disorder (PTSD). However, the few studies ofindividuals who have experienced traumas related to combat or rape suggest that CBT strategies (such as imaginal exposure or stress management) are effective for overcoming and preventing PTSD (18) (19) (20) .
Schizophrenia
Evidence shows that CBT may help to improve social skills, self-care, and independent living skills and decrease aggressive behaviour among patients with schizophrenia (21) . Perris and Skagerlind (22) and Alford and Correia (23) offer promising approaches to modify delusions and effect the patient's view of self. In addition, behavioural treatments may help to decrease the amount ofmedication needed by patients as well as to increase the time between relapses. For example, Hogarty and others compared 4 treatment conditions with respect to relapse rate in the first year following treatment with 1) social-skills training, 2) family psychoeducation, 3) social-skills training plus family psychoeducation, and 4) no psychological intervention (24) . All patients received fluphenazine. The l-year relapse rates for the 4 groups were 20%, 19%,0%, and 41% respectively. A cognitive approach to hallucinations was developed by Bentall and others (25) .
There is a continuing need to develop nonpharmacological treatments that target resistant symptoms, cognitive deficits, and other psychological aspects of the illness (26) .
Sexual Dysfunction
Various cognitive and behavioural strategies have been used successfully to treat sexual dysfunction in men and women. These include systematic desensitization, cognitive therapy, masturbation training, and assertiveness training (18, 27) .
Behavioural Medicine
Recent reviews concluded that CBT can help reduce distress in patients undergoing surgery and patients diagnosed with serious illnesses such as AIDS and cancer (28, 29) . In addition, CBT has been used effectively to decrease high-risk sexual behaviour in adolescents. Finally, CBT strategies are effective for managing various psychophysiological disorders, including chronic pain, tension headaches, irritable bowel syndrome, obesity, arthritis, and insomnia, and forde. creasing type A (coronary prone) behaviour. CBT may beeffective (although evidence is mixed) for treating hypertension and migraine headaches as well.
Alcohol Abuse
Several cognitive and behavioural strategies have been attempted with patients who abuse alcohol. Some of these include social-skills training, communication training, contingency-management training, and cue exposure (18) .
Bulimia Nervosa
CBT tended to be equally as effective as other nonbehavioural interventions, including supportive psychotherapy, IPT, and group therapy. In some cases, CBT was more effective than other approaches when improvement was measured immediately following treatment.
Personality Disorders
Controlled studies of CBT for personality disorders are limited. Among these, Linehan and others (30) found that their version of CBT, "dialectical behaviour therapy" (including skills training, contingency management, cognitive therapy, exposure to emotional cues), was more effective than traditional psychotherapy for decreasing parasuicidal behaviour, hospitalization time, and premature termination oftreatment among patients with borderline personality disorder (BPD).
Group Psychotherapy
The original psychotherapy-outcome metaanalysis by Smith and others concluded that group therapy is an effectivemodel of intervention (31) , with an average effect size of0.83, finding that the average treated person was more improved after psychotherapy than were 80% of wait-list control subjects (32) . An identical finding was noted by Robinson andothers in a metaanalysis ofgroup-psychotherapy studies of thetreatment of depression (33) . Subsequent reviews (34, 35) and metaanalytic reviews (36) (37) (38) further document the general effectiveness of group therapy as significantly superior to nontreatment.
Group therapy plays an important role in treating elderlypersons, and significant and durable treatment effects havebeen shown for the treatment of geriatric depression (39) (40) (41) .
Behavioural and cognitive-behavioural group therapies have been effectively employed for a range of anxiety disorders (42) . Significant and durable improvements have been shown in treating agoraphobia and panic disorder (43, 44) , social phobia (45) , and OCD (46) . June 1999 Practice and Roles of the Psychotherapies 21S Group therapy has been effective in treating eating disorders, particularly bulimia nervosa (47) and binging without purging (48) .
Group therapy has long been recognized as useful in treating patients with personality disorders, as documented in qualitative reviews (49, 50) , and this clinical impression was recently substantiated by research documenting the effective use of group therapy in the homogeneous treatment ofBPD (51) (52) (53) and a heterogeneous range of personality disorders (54) .
Group therapy has been effective in treating patients with PTSD (55-57) and substance abuse and alcoholism (58) .
Group therapy approaches have been effective with nonpsychiatric patient populations as well, with significant effectiveness, notably for patients with HIV and malignancies (59), both primary and secondary, using both cognitivebehavioural approaches and interactive approaches emphasizing social supports.
Couple Therapy
A good outcome in couple therapy is defined as a lessening of relational conflict and distress and a redefinition of ways to resolve conflicts. Alternatively, the realization that the relationship is unworkable and that both partners' well-being can only be achieved through separation or divorce also constitutes a positive outcome.
In a critical review of marital-therapy outcome research, Wesley and Waring (60) concluded that no single approach (behavioural marital therapy, cognitive marital therapy, emotion-focused marital therapy, or insight-oriented marital therapy) proved to be superior to the others. These authors propose a standard for efficacy studies, in which a positive outcome for a form ofmarital therapy would produce subjective and objective improvement in 50% of eligible couples and would be maintained for 1 year. They argue that a waitlist control group is not appropriate for ethical reasons. Further, they suggest that no marital-therapy outcome study has included enough couples (63 in each treatment group) to offer a suitable standard for determining an effect size.
Alexander and others reviewed outcome research in couple therapy through its impact on symptoms and couple satisfaction (61) . Studies included self-report of couples and observational scales. Improvement rates varied from 50% to 83%.
Alexander and others report also that most couples who receive standard marital-therapy interventions show more improvement than do the control couples (61). Johnson and Greenberg in a study of 45 couples reported significant improvement in couples receiving emotion-focused treatment at 2-month follow-up, compared with couples treated with a problem-solving approach and a wait-list control group (62) .
Couple therapy has been studied in various clinical conditions. It has been shown to be an effective adjunctive treatment for depression (63) (64) (65) and for agoraphobia (66, 67) . Among alcoholic patients, couples receiving marital therapy do better than controls on both marital and drinking measures (68, 69) . In a study ofcouples where one partner experienced a disorder ofsexual desire, Hawton and others reported an 84% improvement (70) .
In studying unsatisfactory outcomes in couple therapy, Anderson and others (71) showed that therapies which maintain high intensity, encourage conflict escalation, and emphasize advice-giving produce the highest drop-out rate. Allgood and Crane found that treatment dropouts from marital therapy had fewer children and tended to present with problems related to individual or family-of-origin issues, rather than with problems related to the interaction between the partners (72).
Family Therapy
Alexander and others suggest that the complexities in marital therapy are magnified in family therapy (61) . The treatment unit is more variable, and because ofthe resistance and affects of multiple individuals, most conflicts are intensified. Many families presenting for therapy have multiple problems.
Outcome and Efficacy 1. Schizophrenia. Family psychoeducational programs and family therapy integrated with pharmacotherapy offer a delay in relapse and improved social functioning (73).
Affective Disorder.
Keitner and others found that family therapy plus pharmacotherapy results in improved family functioning and recovery from an adolescent depressive episode (74). Clarkin and others showed that inpatient family interventions were effective for bipolar patients but not for unipolar patients (75) . They suggested that patients who are too depressed cannot benefit from family psychotherapy. Waring and Patton reported that depressed women can be helped with marital therapy and that those who rate intimacy in their marriage as low remain more depressed than do women who rate intimacy in their marriage as high (76).
Anorexia Nervosa.
Family therapy can be helpful for adolescent females with anorexia, provided the duration of the disorder is less than 3 years (77,78).
Conduct Disorder.
Family therapy can playa positive role in adolescent conduct disorder and adolescent suicide (79, 80) . In treating adolescents, Henggeler and others reported that a flexible, individual, community-based intervention was effective in a large group of delinquent adolescents (81) . Social, learning-based parent-training approaches for parents of aggressive children and preadolescents have proven effective (61,82).
Suicide.
Family therapy may prove helpful to a family following the suicide of one of its members (83, 84) .
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Alexander and others' metaanalysis of 20 years of family therapy showed positive effects, compared with no treatment or placebo treatment (61) . However, these authors concluded that the superiority of family therapy to other modalities has not been substantiated. Gurman and others concluded that 73% of family cases improved during treatment (82) . Recent reviews of the positive impact of couple and family therapy on a clinical population have been published (79, 85, 86) .
Negative Outcomes
Gurman and Kniskern report that poor outcomes of family therapy are associated with therapists who have poor relationship skills and confront patients directly about loaded issues and with therapists who fail to intervene when there is serious confrontation between family members (87). Coleman and others edited a multiauthored volume entitled "Failures in Family Therapy" (88) . It is commendable to publish negative results; therapists could otherwise obtain a false sense of security, unaware that therapy may harm some patients.
Psychotherapy With Children and Adolescents
Several methodological improvements have occurred over the past 15 years. Assessment tools have become much more standardized. Diagnostic interviews for children (89, 90) and symptom rating scales for depression, anxiety, tics, eating disorders, obsessions and compulsions, and hyperactivity are now available.
Treatment approaches for children have been operationalized. Therapy manuals exist for psychoanalytically oriented treatments (91), family therapy (92), cognitive therapy (93), parent training (94), social-skills training (95), mother-infant interventions (96) , and briefpsychotherapy ofvaried modalities (97), to name but a few.
Behaviour modification and cognitive-behavioural techniques account for about one-halfofall treatment studies over the past 20 years (98).
Fonagy and Target undertook a retrospective chart review of more than 750 cases of child psychoanalysis and psychotherapy at the Anna Freud Centre (99) . The authors found that long-term (longer than 6 months), intensive (4-5 times weekly) therapy was significantly more effective than shortterm (less than 6 months), nonintensive (1-3 times weekly) therapy for preadolescent patients, while the reverse was true for teenagers. Children with internalizing disorders did better than those with externalizing disorders, but the difference disappeared when intensity and duration of treatment were controlled for. Intensive treatment was especially beneficial when the disorder was severe. When the disorder was less severe, there was no difference between intensive and nonintensive therapy. The study findings may not be generalizable because ofa selection bias ofthe clinical population, the lack ofcontrol subjects, and the retrospective nature ofmeasuring improvement.
Does child therapy work? If one takes a broad-based metaanalytic approach, then the answer is "Yes." Studies that include age ranges 2-18 years and cut across modalities and types ofproblem as recently as 1995 show mean effect sizes ranging from 0.71 to 0.84 (100) (101) (102) (103) (104) , which is similar to outcomes in metaanalytic studies of adult psychotherapy. The average child after treatment functioned better than did 78% of control-group children.
Nevertheless, a specific treatment is likely to vary in effectiveness as a function of child, parent, family, community, therapist, therapy, and temporal or developmental factors.
Aggressive and antisocial behaviour (conduct disorder) is one ofthe most extensively studied problem domains. Patterson and others have demonstrated improved behaviour at home and school (105) . Long-term improvement has been difficult to document.
CBT for depressed children and adolescents has resulted in significantly reduced functional impairment and depressive symptomatology, compared with placebo discussion groups, waiting list only, and no treatment (106) .
Metaanalytic studies of family therapy show effect sizes ranging from 0.45 (107) to 0.70 (108) . Diagnostically, the greatest family-therapy successes have appeared for children with schizophrenia, for which psychoeducation to reduce "expressed emotion" reduces the probability ofrelapse (109) and rehospitalization (110) ; family members with anorexia nervosa and bulimia, in which weight gain and normal menstrual functioning are better maintained than with individual therapy (111); and children with conduct disorder, whereparent management training (112, 113) , functional family therapy (114) , and multi systemic family therapy (115) have all resulted in lower recidivism rates among delinquents and improved family functioning.
A metaanalysis of child and adolescent psychotherapy effectiveness concluded that research evidence for efficacy is clearer for behavioural than for nonbehavioural therapy (102,116).
Brief Therapy

Outcome Studies
Howard and others examined the "dose-effect" relationship in psychotherapy (117) . They reported a metaanalysis of 2431 outpatients with varying diagnoses and lengths of treatment over a 30-year period. The results indicate that, by the 8th session, approximately 50% of patients measurably improved and that 75% improved within 26 sessions. Koptaand others analyzed the dose-effect relationship of 854 psychotherapy outpatients by examining differential dose-effect curves in relation to 3 classes of symptoms (118) . Acute June 1999 Practice and Roles of the Psychotherapies 238 distress symptoms showed the highest average percentage of patients recovered, across doses, compared with the other 2 classes. These studies clearly illustrate the large therapeutic gains that patients can acquire in a brief amount of time. Further, this research highlights the importance of selection criteria in determining which patients would be more suitable for long-term treatment. We need more studies of patients with chronic psychiatric symptoms, severe trauma, and characterological disorders, which often require long-term therapy to attain remission and prevent relapse. Other studies, using Mann's time-limited psychotherapy (119) and shortterm anxiety-provoking psychotherapy (120) with trained therapists, confirm that symptomatic improvement is stable over follow-ups at 6 months, 12 months, and even 2 years. This is consistent with a general trend in psychotherapyoutcome research that gains achieved during therapy are maintained after therapy (121) .
Comparative Outcome Studies
A comprehensive review by Lambert and Bergin (121) and Robinson and others (122) of comparative outcomes for depressive disorders showed that verbal therapies were inferior to CBTs. However, once treatment allegiance was accounted for through regression analysis, the outcome of all therapies was equivalent (121) . Sloane and others randomized 90 outpatients to short-term analytical psychotherapy, behaviour therapy, and minimal-treatment while on a wait list (123) . No differences in outcome were found between the 2 treated groups, and this was replicated at the 8-month follow-up. This well-designed study was reinforced by the National Institute of Mental Health (NIMH) collaborative depression study (124) , and more recently, Shapiro and others concluded that briefpsychodynamic-interpersonal therapy and CBT are equally effective for depression (125) .
Metaanalysis and BriefPsychotherapy
Smith and Glass reviewed 400 controlled psychotherapy outcome studies by metaanalysis (126) . Their results include that effective treatment is achieved by a mean 17 sessions and that short-term approaches are significantly effective. Similarly, Crits-Christoph's rigorous metaanalysis of 11 brief dynamic psychotherapy studies provides evidence that brief dynamic therapy is about equal to cognitive and behavioural therapies, as well as to medication (127) . Diguer and others confirmed previous studies that various psychotherapies do not differ in effectiveness (128) .
Psychotherapy Process Research
Process-outcome studies identify specific events within psychotherapy sessions and determine whether their occurrence or absence is correlated with or predictive of outcome (129) .
Significant predictive results of positive outcome have been found for the following factors: severe psychiatric pathology, positive therapeutic alliance, and accurate interpretations (130) (131) (132) . Piper and others have also demonstrated that the quality of object relations is a strong predictor of therapeutic alliance and psychotherapy outcome (133) . Further, group therapy has been used effectively in a brief format. Many authors are now focusing on measuring interpersonal relationship patterns and their significant impact on outcome (134) (135) (136) (137) .
Conclusions
Brief therapy is currently underused in Canada, despite its clear advantages and proven efficacy.
Long-Term Psychiatric Care
Although there is general agreement that most serious psychiatric illnesses either endure or frequently return, there is surprisingly little consensus about the need for continuity of psychiatric care. Some advocate the consultation model (ongoing treatment by a family physician with "as-needed" consultations by different psychiatrists). Others advocate the case management model, where continuity is provided by a nonmedical case manager (which position may be filled by different individuals) with the psychiatrist serving as a peripheral member of the treatment team. Others support the role ofpsychiatrist as long-term primary care provider for seriously ill patients with enduring or relapsing illnesses. This means a long-term commitment to those patients with regular (not necessarily frequent) contact over many years and essentially permanent access to further treatment as needed.
The essence ofproviding long-term psychiatric care is giving patients access to intermittent but known and trusted caregivers.
Long-Term Psychotherapy
Efficacy and Cost-Effectiveness ofLong-Term Psychotherapy
Certain methodological problems are involved in studying long-term therapy. We need more data and better conventions to measure improvement. Banon and others conducted a metaanalysis ofthe outcome studies ofpsychotherapy for patients with personality disorder (138) . They identified all studies that used systematic means of making the diagnoses, incorporated valid outcome measures, and allowed for the calculation of magnitude of effect. The correlation between the remission and the duration oftreatment was investigated. studies of BPD resulting in a remission rate of 3.7% yearly, necessitating 24 years for 100% total remission (139) .
Further, these authors found that once-weekly sessions led to 50% remission after 2.45 years and 100% remission after 8.7 years. With twice-weekly sessions, these figures were halved to 1.22 and 4.3 years respectively.
In another series ofstudies, patients with a diagnosis ofa BPD manifesting self-mutilation, with or without suicidal intent, were conducted by Linehan (140, 141) . The experimental group received weekly individual and group psychotherapy sessions for 1 year, compared with a control group that received "treatment as usual," averaging 20 sessions yearly on an outpatient basis. The results indicated that the yearly average number ofself-mutilation incidents was 1.5 (ofless medically severe nature) for the experimental group, compared with 9 for the control group. The number of inpatient days yearly was 8.6 for the experimental group and 38.86 for the control group, a highly statistically significant finding. Further, the experimental population, on average, worked 5 weeks more every year than did the control group. Regarding the cost of psychiatric hospitalization, the experimental group averaged $6083.00 and the control group $27 940.00, which constitutes significant savings (142) . The gains achieved by the experimental subjects were generally maintained at 1 year follow-up, one-halfofthem remaining in therapy beyond 1 year. Linehan opines that 1 year of therapy is too short and that 2 years are required for treatment effects to stabilize, at which point 20% will remain stable, while 50% will relapse within 2 years and will require 2 more years ofintensive therapy.
A recent prospective study examined the outcome of intensive psychodynamic psychotherapy, an average of 25.4 months, for 23 patients with personality disorder. The findings, beyond symptomatic improvement, indicated that 75% of patients who met Axis I diagnosis criteria and 72% who met Axis II diagnosis criteria no longer fulfilled these diagnostic criteria after therapy. At 5-year follow-up, the findings showed statistically significant improvement on scores for symptoms, characterological defences, and affectivity, while 68% reduction in personality disorder diagnosis was maintained (143) .
Luborsky and others recently reviewed all studies that compared psychodynamic treatments with other well-known treatments (such as CBT, behavioural, group, and experiential treatments) (144) . To be included in the review, studies had to score well on a list of criteria for good psychotherapy studies. He concluded that outcome was generally quite comparable in many patient populations.
Numerous recent studies on patients with personality disorders show that psychodynamic psychotherapy is effective in ameliorating personality difficulties, even in its early to mid stages of treatment. Stevenson and Meares of Australia evaluated the effectiveness of a psychodynamic psychotherapy for patients with BPD (145) .
In Norway, Monsen and others reported on a prospective study ofpatients with personality disorders receiving psychodynamic psychotherapy (146) . The majority of patients had previously tried less intensive forms of treatment. At treatment completion, 72% ofpatients no longer qualified as having a personality disorder. These gains were maintained at 5-year follow-up.
Depression. There is now evidence that longer-term treatment may be necessary for depression. The NIMH Collaborative Study of Depression, a very highly regarded multicentre control study of 16 weeks ofmedication, CBT, and IPT treatment for depression, initially showed good results at 16 weeks but had very disappointing results at l8-month follow-up (147) . Klerman and Weissman, who developed the short-term interpersonal approach used in the study, wrote: "The percentage of patients who had recovered during acute treatment, but who remained well over the 18-month followup, was disappointingly low, ranging from 19% to 30%. The rate ofrelapse for those who recovered-30% to 50%-was disappointingly high. These rates were not significantly different between [NIMH] treatment groups" (148, P 832). Shea and others conclude that "16 weeks ofthese specific formsof treatment is insufficient for most patients to achieve full recovery and lasting remission" (147, P 782). Clearly brief psychotherapy or brief medication is not the answer to all depressed patients' needs. It appears that current short-term therapies are more effective at relieving symptom distress than in improving patients' adaptive functioning (149) . Certainly we need to study further how to measure improvement and how to maximize improvement with cost-effectiveness.
Blatt and others from Yale University have begun to further separate out subgroups of depressed patients who need longterm treatment (150) . Recently they analyzed data from the NIMH study and found, for example, that self-critical patients (who are more likely to attempt suicide) did not improve in any of the treatment conditions, all of which were short-term (medication, IPT, CBT, and clinical management). Blatt and Ford have recently shown that inpatients who are self-critical and receive psychodynamic psychotherapy 4 times weekly do improve after 15 months of treatment (151) . "Perfectionistic patients do poorly in brief treatment for depression, they are significantly more responsive to long-term, intensive psychoanalysis and psychoanalytically oriented inpatient treatment" (150) .
Consumer Satisfaction. Because of important limitations on the methodology ofcontrol studies, it is essential that control studies be supplemented by natural studies, which examine patient satisfaction with psychotherapy as it is actually practised. Seligman has reviewed several limitations of control trials (152) . For instance, in random clinical trials, therapists June 1999 Practice and Roles of the Psychotherapies 258 are assigned to patients; in practice, patients actively seek out the kind oftherapist they want. In psychodynamic treatments "the patient-therapist match" is shown to be very important. The recent, massive Consumer Reports survey showed that patients are very pleased with their long-term treatments (152) . Of4000 readers surveyed, almost all who sought psychotherapy reported improvement and longer treatment length (which included the psychodynamic treatments), which correlated with better outcomes. Those in managed care had worse outcomes.
The Economic Impact ofPsychotherapy
Cost of treatment defies simplification and involves consideration of the following issues: cost-minimization-for example, psychotherapy is less expensive than alternative methods; cost-effectiveness-that is, the combination ofcost analysis with a single endpoint (such as a depression-free episode); cost-utility, where multiple clinical endpoints are summarized into a single measure (such as work performance following psychotherapy-induced relief from BPD diagnostic criteria); cost-benefit analyses, where clinical effectiveness is expressed not in terms of disorder-free episodes or attrition in suicide rate but in monetary terms (153) .
A study of the cost-minimization of combining psychotherapy and antidepressants in treating hospitalized depressed patients demonstrated that spending, on average, $257.50 on psychotherapy saved $25 405.00 for each hospitalized patient due to shortened length of stay, which represents almost $100.00 of savings for every dollar spent on psychotherapy (154) . The same investigator found that monthly psychotherapy maintained freedom from relapses for almost twice as long as did clinical management and placebo.
The expansion ofpsychotherapy coverage by the CHAMPUS program, which provides health care insurance for US military personnel and their families, resulted in a net savings of $200 million during the 4-year study, 1989-1992. The costoffset was the result of reduced use of inpatient services. For every $1.00 spent on psychotherapy, $4.00 was saved in accrued inpatient costs (155) .
Wereport here one finding ofan early cost-offset study; its results converge with those of more recent studies, and the effects of psychoanalysis, and not only of intensive psychotherapy, were investigated. In Germany, 845 patients receiving these 2 modalities oftherapy required significantly lessmedical hospitalization during a 5-year period, compared with a sample that did not. Prior to treatment, psychotherapy patients averaged 5.3 days in hospital, compared with 2.5 days for the control sample. However, 5 years posttreatment, the average for the psychotherapy patients was 0.78 days yearly (156) . Despite these results, the German health care system years later saw fit to deinsure intensive psychotherapy and psychoanalysis, only subsequently to reinstate them when it was shown that their cost-benefits were so substantial that even psychoanalysis paid for itself over the years.
A natural experiment ofthe effects oflimiting outpatient psychotherapy coverage in New Zealand compared with that in Australia was published. Australia was found to have twice the number of psychiatrists and one-half the number of psychiatric beds per capita, compared with New Zealand. Further, the population in some areas of Australia enjoys unlimited health insurance coverage of outpatient psychotherapy on a fee-for-service basis. The findings showed increased burden on state-hospital beds and higher per capita mental health expenditure in New Zealand, mainly due to the greater rate of bed use-126 beds per 100000 costing $7 million, compared with Australia at the rate of74 beds per 100 000 at a cost of $4 to $5 million. The demographic characteristics of both countries are similar. Treatment options in New Zealand are largely biological, while in Australia, intensive psychotherapy and psychoanalysis are also available (157).
A recent review of the available psychotherapy studies that emphasize the economic effects produced by psychotherapy concluded that 80% of the randomized clinical studies and 100% of the nonrandomized trials indicated that psychotherapy reduces several costs. In combination, 16 of the 18 (88.9%) studies reviewed yielded evidence of a beneficial economic impact in treating severe and chronic psychiatric disorders, including schizophrenia, bipolar affective disorder, and BPD. This impact results from reduced inpatient care and reduced work impairment (153).
Continuing Medical Education
The profession of psychiatry is in a state of substantial ferment. A particularly heated focus relates to the role of psychotherapy in the practice of psychiatry (158) (159) (160) . This controversy is particularly ironic in light ofthe fact that "there are now well over 500 studies that attest to the efficacy ofpsychotherapy ... ; it seems that psychotherapy is one ofthe best documented medical interventions in history" (161) . At a time of the greatest empirical support for the efficacy ofpsychotherapy, it is under its greatest threat; this raises the key issue, not of effectiveness, but of accountability.
As the major professional psychiatric organization in Canada, the CPA must assume responsibility for fostering, through continuing education, the accountable and effective practice of psychotherapy. This may begin by performing a detailed needs assessment of practicing psychiatrists, to better shape and guide the necessary retooling and retraining that developments in contemporary psychiatry and psychotherapy demand. Formats to ensure sufficient intensive and extensive exposure are required to actually modify clinician behaviour. We suggest several foci for continuing education in the psychotherapies to reflect the current state of research, 26s
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This may necessitate addressing certain ideological resistances to the applications of these psychotherapeutic approaches. Although the efficacy of CBT and IPT in the treatment of depression and anxiety disorders is substantial, Persons and others note that traditionally trained psychodynamic therapists experience significant reservations in learning to practice CBT (162) . Fundamental misconceptions about CBT include those regarding the nature ofthe therapeutic relationship in CBT, the focus ofCBT interventions, and the depth of change effected. Yet, when these resistances are overcome, psychiatrists are able to employ a broader range of interventions, both as stand-alone and as part of psychotherapy integration (163) . It is the integration of psychotherapy and psychopharmacology that is a unique strength ofpsychiatry and offers particular potency in the treatment of depression, both in the acute and maintenance phases (164, 165) . Hence, continuing education should include examining models of integration, their strengths and limits, and the potential to misapply integration, looking to common factors, technical eclecticism, and/or an overarching metatheory to guide clinical strategies (166) .
In the area ofbriefdynamic psychotherapy, Barber highlights the fact that dynamic therapists often employ techniques best suited for long-term therapies, although they are compelled both by patient choice and potential coverage restrictions to treat patients over a shorter period of time (167) . Continuing education opportunities to enhance the practitioner's ability to identify, collaboratively, a focus oftreatment and maintain the proper balance of support and expression for effective treatment are essential. Issues of selection and focus become ever more important in brief dynamic psychotherapies. Recognizing the limits and applications of short-term therapies and the role of long-term dynamic psychotherapy is critical (168, 169) .
The CPA must foster further rapprochement between research and therapy (170) , helping to translate research findings into practical, clinical strategies, dispelling the anachronistic view that laboratory research relates little to actual clinical practice. It is essential in this regard to incorporate the findings of naturalistic studies (161) , reflecting what occurs in the real setting of psychotherapy with real patients and real therapists (171) , and of randomized control trials of psychotherapy (168) .
Howard and others recommend a model of easily employable, critical evaluation to provide clinical feedback regarding the status and progress of ongoing psychotherapies that can inform both patient and therapist (161) . Such evaluation translates the clinical relevance ofresearch from a conceptual issue into one of practical clinical application. This can be achieved through measurements of therapeutic bond, mental health index, and clinical assessment index. This additional form of check and balance may help enhance accountability by identifying, early on, treatments that are not progressing and which may require consultation or alternative treatment approaches.
In addition to specific areas of psychotherapy, continuing education should also address the psychiatrist's role as a consultant to other allied health professionals. Continuing education opportunities should help Canadian psychiatrists to establish effective, collaborative, consultative alliances with individual practitioners or agencies and to develop the capacity to observe, listen, and respond in a way that recognizespatient, therapist, interactive, and systemic contributions to treatment success, stalemate, or negative outcome (172) . Related functions include the ability to identify problems thatrefleet misapplication of technique or countertransference (173) or problems that emerge from an initial inadequate or inaccurate understanding of the patient (174).
The Cost-Effectiveness of Psychotherapy
The study ofthe cost-effectiveness oftreating medical conditions is a relatively new area ofstudy. This is particularly true for psychiatric conditions and even more so for the area of psychotherapy.
Efficacy
The evidence demonstrating the efficacy ofpsychotherapy is plentiful and consistent. Compared with wait-list, notreatment, or minimal-treatment conditions, the psychotherapies have been shown to be effective at reducing symptoms and improving global and social functioning, among other specific effects (175) . This is important because if atreatment is not efficacious, it cannot be cost-effective either. Comparative studies of the efficacy of psychotherapy generally have not found robust differences between treatments. Nonetheless, even if 2 treatments are found to be equally effective, compared with, say, a placebo or wait-list condition, onemay still be associated with fewer costs and therefore be more cost-effective.
The Study ofCost-Effectiveness
The idea of studying the cost-effectiveness of psychotherapeutic treatments versus no treatment or other active treatments has only recently been raised in the general psychiatric literature. Krupnick and Pincus pointed out the discrepancy between the vast literature demonstrating the efficacy ofpsychotherapy and the sparseness of literature on its costeffectiveness (176) . June 1999 Practice and Roles of the Psychotherapies 278 One landmark study examined maintenance treatments for recurrent depression among individuals who recovered from major depression and stayed well for 17 weeks (177) . After recovery, these individuals were randomized to 1 of5 maintenance conditions: placebo, once-monthly maintenance sessions ofIPT (IPT-M), IPT-M plus placebo, imipramine, or IPT-M plus imipramine. Using the data on relapse obtained on follow-up and applying several estimates, they modelled the data. Using cost-utility analysis, they first estimated the quality of life for subjects in each condition for the rest of their life. This assumed that the risk for depression associated with each condition was stable over time. They then calculated the different effects for each treatment condition as the costs for each additional quality-of-life year that would be obtained by one condition compared with another over time.
Thus they could estimate whether a treatment condition was effective, did or did not reduce medical costs, and was costeffective compared with another. Much of the data for their estimates, such as the quality oflife during depression as opposed to when well and the likelihood that the hazard for recurrence would remain stable until the end oflife, were based on other studies, often only one. They demonstrated that both active treatments improved health outcomes in comparison to placebo, but that only the drug-alone condition also reduced health care costs. The drug alone and IPT-M plus drug were more effective and cost-effective than was IPT-M alone. The drug plus IPT-M treatment also improved the quality oflife, with costs that are generally within the range of those for "cost-effective treatments," in most medical studies defined as less than US$50 000 for each additional quality-of-life year. The generalizability of the authors' conclusions is affected by the many conditions and assumptions in the study. For instance, the authors assumed that psychotherapy maintenance would not have a cumulative effect of decreasing the hazard function for relapse over time. Thus, the results would not necessarily generalize to a long-term psychotherapy study that aimed at reducing that hazard by treating (decreasing) the psychological vulnerability to the trigger mechanisms for recurrence. In other words, the treatment model under study limits the conclusions to monthly maintenance treatment situations, which may differ from the real-life treatments offered by psychotherapists treating recurrent depression. Another limit to generalizability is that the study pertains only to patients who had a full recovery from their index episode ofdepression and remained well for 17 weeks before being accepted into the maintenance study. In fact, psychotherapy might be most likely to be prescribed for patients who do not have a full recovery with or without drug treatment or who relapse quickly or have frequent recurrences despite adequate trial on antidepressant medication.
Gabbard's paper, which demonstrates cost-effectiveness of psychotherapy, may be useful to generate future research (153) . He reviewed the literature and stated that the findings of 8 of the 10 clinical trials with random assignment (80%) and all 8 of the studies without random assignment (100%) suggested that psychotherapy reduces total costs.
Uses and Limits ofCost-Effectiveness Studies
Richard Frank (178), a health economist specializing in mental health, stated that the challenge for policy research is "to formulate approaches for decision making that balance concerns related to errors such as: (1) paying for ineffective care;
(2) excluding effective treatments, and, (3) covering treatments shown to be cost effective that are not used 'cost effectively. '" He notes that "issues of cost-effectiveness are often raised in connection with mental health in a rather cynical manner in order to justify reduced budgets in public programs or to avoid paying for programs that attract 'bad risks' in private insurance." Finally, once decisions are made, they may be vitiated by changes in how things are paid for. For instance, Frank notes that "cost-shifting has long been a pervasive strategy in the mental health sector." A decision that is cost-effective for a funding source may not be so for an agency carrying out the actual treatment, if costs are shifted downward as a result. Thus there are many caveats to how the existing literature might be interpreted, and there is no substitute for developing an empirical literature that addresses questions specific to the health care environment ofthe Canadian provinces.
Conclusions
Educational authorities and professional associations in many countries identify the psychotherapies as essential clinical skills for psychiatrists.
Despite this agreement, current teaching in the psychotherapies is deficient. We identified 2 reasons. Faculty members lack expertise in the newer therapies. Also, long-term psychotherapies are underused, which deprives students from developing these skills.
Current research has provided significant evidence for efficacy ofmost major modalities. Cost-effectiveness studies are promising, but they are a new development.
Psychotherapies are core services to which patients wish and require access.
Improvements are necessary in training, in continuing medical education, and in accountability of the current system.
For a psychiatrist to function effectively as a supervisory consultant or leader of a multidisciplinary team, some psychotherapeutic knowledge and skill is essential.
Balancing short-and long-term as well as newer therapies is desirable.
In research, promising new studies are demonstrating how psychotherapeutic and computerized interventions generate changes in brain metabolism. It may be that an empathic, 288 The Canadian Journal of Psychiatry Vol 44, Suppll nurturing relationship over time changes neural mechanisms. More study will be needed to explore this. Newer techniques, integration of therapies, and combination of psychotherapy with pharmacotherapy are areas for further research.
The combination ofpharmacotherapy and psychotherapy can enhance outcome in many psychiatric disorders.
Psychotherapy should be available to all patients, including those with serious illnesses, those with mental and physical disabilities, elderly individuals, and those from other cultures or of different sexual orientation or who are economically disadvantaged.
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